Skip to content

Effect of Pectointercostal Fascial Block on postoperative pain and rapid recovery in patients undergoing cardiac surgery

Effect of Pectointercostal Fascial Block on postoperative pain and rapid recovery in patients undergoing cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081148
Enrollment
Unknown
Registered
2024-02-23
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Median open heart surgery

Interventions

Control group:No PIFB will be performed. Intravenous analgesia pump (PCIA) will be used after surgery. The drug formula is Sufentanil 2.5µg/kg+ esketamine 1mg/kg+ dexmedetomidine 2.5ug/kg, diluted to
Pectointercostal fascial block with a constant basal infusion:On the basis of the general anesthesia group, bilateral thoracic intercostal fascia block was added, 0.375% ropivacaine 20 ml was injected
Pectointercostal fascial block with a automated intermittent boluses infusion:On the basis of the general anesthesia group, bilateral thoracic intercostal fascia block was added, 0.375% ropivacaine 2

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients =18 years of age undergoing elective classical open-heart surgery.

Exclusion criteria

Exclusion criteria: 1. Patients and their families refused to participate in the study; 2. Allergic to amide local anesthetics; 3. Patients who are unable to carry out normal communication and evaluation due to factors such as language impairment, hearing impairment, and mental illness; 4. Patients with grade IV heart function; 5. Pre-existing neurological disease; 6. Preoperative coagulation dysfunction; 7. Patients with infection in the puncture and catheter indwelling area; 8. People with sepsis.

Design outcomes

Primary

MeasureTime frame
Sufentanil consumption;Resting and dynamic VAS scores after extubation;

Secondary

MeasureTime frame
24h, 48h, 72hQoR-15 scores after extubation;IL-6, IL-10, TNF-a levels;Mechanical ventilation time;ICU stay time;Time to get out of bed;Recovery time of gastrointestinal function;Incidence of postoperative delirium;Incidence of postoperative chronic pain;Incidence of postoperative chronic pain;The incidence of other postoperative complications;

Countries

China

Contacts

Public ContactZhi Ye

Xiangya Hospital, Central South University

yezhi523@csu.edu.cn+86 150 8482 5252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026